Bluesky · Hashtag

#AtopicDermatitis

28
posts · 30d
15
users
1
posts / day
1.9
posts / user
-50% vs last week

#AtopicDermatitis is an active hashtag on Bluesky. In the last 30 days, 15 people shared 28 posts with it — around 1 a day. Activity is down 50% versus the previous week, peaking on Jul 17 with 3 posts.

#AtopicDermatitis posts per day (last 30 days)

Related tags

Tags most often used together with #AtopicDermatitis.

Posts with #AtopicDermatitis

Ultragross
@ritualacts.bsky.social
over 1 year ago
Went to the dermatologist today n got started on dupixent again so hopefully my skin will be a lot better going forward #atopicdermatitis
Jone wearing a golden yellow tank top n black sweater with a chainmail necklace looking bored into the camera
Jone wearing a golden yellow cropped tank top with a black sweater taking a mirror selfie in a bathroom with floral wallpaper
6 0 35
Dr. Susan Winters ☕️
@docwinter.bsky.social
9 months ago
💥 BREAKING: Study of 11,000+ kids with eczema shows COVID vaccine not only protects from COVID but slashes risk of other infections & allergies! 🦠✨ Science is saving lives in ways we never imagined. #MedTwitter #COVID19 #AtopicDermatitis #VaccinesWork #Pediatrics #HealthScience
COVID-19 Vaccination Linked to Reduced Infections in Children with Eczema - ACAAI Patient

acaai.org

COVID-19 Vaccination Linked to Reduced Infections in Children with Eczema - ACAAI Patient

Children with eczema may experience fewer allergic complications if they receive the COVID-19 vaccine, according to new research.

2 3 6
Dermatology Advisor
@dermatologyadvisor.bsky.social
about 20 hours ago
Among patients with #AtopicDermatitis who received stapokibart, 61.5% of patients who received prior systemic therapies had a 75% improvement in #Eczema Area and Severity Index scores. www.dermatologyadvisor.co…
Stapokibart Effective for AD Regardless of Prior Systemic Therapy Use

www.dermatologyadvisor.com

Stapokibart Effective for AD Regardless of Prior Systemic Therapy Use

Stapokibart is safe and effective for the treatment of moderate to severe AD despite a history of systemic treatment use.

0 0 0
Amy Paller, MD
@pallerlab.bsky.social
over 1 year ago
New study on tapinarof cream 1% in pediatric AD! Minimal systemic absorption, favorable safety, and good tolerability in children (2–17 yrs)with extensive AD. The treatment was well tolerated, even on sensitive skin and flexural areas, with only mild folliculitis reported. #atopicdermatitis #dermsky
0 0 4

Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.